Market News Digest — 31st Aug 2026: Pharma gains, rupee rallies, housing finance beckons
Domestic equities buoyed by pharma strength and currency support; global headwinds persist amid geopolitical tensions.
Market Digest: Pharma Strength & Currency Tailwinds 📈
Indian equities kicked off the week on a constructive note, with domestic flows and central bank support underpinning sentiment. The rupee touched its strongest level in nearly a month, buoyed by equity-related inflows and RBI backing, while notching a monthly gain. Offshore headwinds remain, however, as geopolitical tensions between the US and Iran lifted crude prices and bond yields globally, weighing on European bourses.
- 🏥 Pharma: A pharmaceutical major gained ground after its subsidiary launched a generic version of a well-known respiratory therapy in the US market, extending gains for the year-to-date period.
- 💰 Affordable Housing Finance: A domestic research house initiated coverage on five housing finance names with constructive medium-term outlooks, citing meaningful upside scope across the cohort.
- 💼 Smallcap Positioning: Foreign investors have been accumulating stakes in a baker's dozen of smaller-cap names during the quarter, with several rallying sharply from those entry levels.
- 🌏 Global Markets: Asian equities faced mixed fortunes—China and Hong Kong slipped as economic data disappointed and property-sector headwinds persisted, while US policymakers signalled confidence in underlying growth momentum despite bond market volatility.
For live tracking of market developments and detailed analysis, visit momentumiq.in.